Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Biomarin Pharmaceutical Inc Transaction History
Fjarde Ap Fonden (The Fourth Swedish National Pensionfund)
- $8.86 Billion
- Q2 2024
A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 74,269 shares of BMRN stock, worth $5.28 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
74,269Holding current value
$5.28 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.35 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.34 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$991 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$690 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...